The US army stated on Tuesday that American army officers who refuse to be vaccinated against COVID-19 could be suspended from their duties and possibly discharged, Reuters news agency reported on Wednesday.
Following the full approval of the Pfizer (NYSE:PFE)/BioNTech (Nasdaq:BNTX) COVID-19 vaccine by the US FDA in August 2021, Defence Secretary Lloyd Austin had ordered that all active duty service members must get vaccinated.
According to the US Army, it had begun implementing this order in late August, adding that soldiers could request an exemption on legitimate medical, religious or administrative grounds.
The Army stated that commanders, command sergeants major, first sergeants and officers in Command Select List positions who refuse to be vaccinated and are not pending an exemption request would face suspension and relief if they refuse to comply.
"While soldiers who refuse the vaccine will first be counselled by their chain of command and medical providers, continued failure to comply could result in administrative or non-judicial punishment - to include relief of duties or discharge," the Army said.
The Army now expects its active duty units to be fully vaccinated by 15 December 2021 and its Reserve and National Guard units by 30 June 2022.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine